B2DB — Who said what, where, and when

Paul Brennan

Director of Centre for Medicines Discovery, University of Oxford

Paul Brennan is listed as Director of Centre for Medicines Discovery, University of Oxford. B2DB records 2 sessions at 1 conference in 2026, most recently Drug Discovery Chemistry Europe 2026 (November 2026). Speaks mainly at Hospitals and Health Care events.

Compiled from published conference agendas; not yet confirmed by Paul. Is this you? Claim this profile.

About

Paul Brennan received his PhD in organic chemistry from UC Berkeley. Following post-doctoral research at Cambridge University, Paul spent eight years working in the pharmaceutical industry at Amgen and Pfizer. After leaving Pfizer in 2011, Paul joined the Structural Genomics Consortium at the University of Oxford and led the chemical probes discovery effort on epigenetic targets. After leaving the SGC in 2019, Paul was Head of Chemistry and then Chief Scientific Officer of the Alzheimer’s Research UK Oxford Drug Discovery Institute where his research was focused on finding new treatments for dementia. In addition to dementia, over the course of his career, Paul has worked on discovering new medicines for cancer, incontinence, pain, rare diseases, and inflammation. Paul is currently Professor of Medicinal Chemistry and Director of the Centre for Medicines Discovery at the University of Oxford and a scientific advisor to the biotech and pharmaceutical industries. His research centre is f

Sessions at 1 conference

Drug Discovery Chemistry Europe 2026 11 November 2026 – 12 November 2026

Others from University of Oxford

See all 22 speakers from University of Oxford